Rongjun J. Ma
Zhengzhou, 450003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Clinical and genetic characteristics of patients with mucosa-associated lymphoid tissue lymphoma transformed into diffuse large B-cell lymphoma
Journal: Zhonghua yi xue za zhi
Published: May 07, 2026
Stage-specific disruption of erythropoiesis leads to anemia in newly diagnosed multiple myeloma patients.
Journal: Frontiers in cell and developmental biology
Published: October 03, 2025
Identification of the IFN-γ/IL-4 ratio as a prognostic biomarker and development of an immune-related prognostic model in diffuse large B-cell lymphoma.
Journal: BMC cancer
Published: April 30, 2025
Long-Term Survival Following Cladribine Containing Pretransplant Regimen for Autologous Hematopoietic Stem Cell Transplantation in Disseminated Interdigitating Dendritic Cell Sarcoma: A Case Report and Literature Review.
Journal: Journal of blood medicine
Published: January 23, 2025
CD20-positive peripheral T-cell lymphoma not otherwise specified: a case series and review of the literature.
Journal: Frontiers in oncology
Published: December 31, 2024
Brentuximab vedotin in treating Chinese patients with lymphoma: A multicenter, real-world study.
Journal: Cancer medicine
Published: May 16, 2023
Effect of laparoscopic ovarian cystectomy on ovarian reserve and the outcomes of in vitro fertilization patients with benign ovarian cysts
Journal: Zhonghua fu chan ke za zhi
Published: February 13, 2023
Effect of triple-induction regimen including all-trans retinoic acid, arsenic trioxide plus anthracyclines for adults with non-high-risk acute promyelocytic leukemia
Journal: Zhonghua yi xue za zhi
Published: August 18, 2021
Correlation analysis of central nervous system relapse and cell biological characteristics in acute promyelocytic leukemia
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: August 12, 2021
Efficacy and safety of PD-1 inhibitor combined with chemotherapy in the primary treatment of phase Ⅲ/Ⅳ extranodal nasal-type natural killer/T cell lymphoma
Journal: Zhonghua yi xue za zhi
Published: April 26, 2021
Last Updated: 09/26/2026